{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T20:04:31Z","timestamp":1770062671455,"version":"3.49.0"},"reference-count":113,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Actas Urol\u00f3gicas Espa\u00f1olas"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/s0210-4806(09)72891-8","type":"journal-article","created":{"date-parts":[[2013,9,9]],"date-time":"2013-09-09T19:25:12Z","timestamp":1378754712000},"page":"941-951","source":"Crossref","is-referenced-by-count":27,"title":["Hipoxia tumoral. Papel del factor inducible por hipoxia"],"prefix":"10.1016","volume":"33","author":[{"given":"Avelino","family":"Fraga","sequence":"first","affiliation":[]},{"given":"Ricardo","family":"Ribeiro","sequence":"additional","affiliation":[]},{"given":"Rui","family":"Medeiros","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0210-4806(09)72891-8_bib1","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1101\/gad.14.16.1983","article-title":"HIF-1 and human disease: One highly involved factor","volume":"14","author":"Semenza","year":"2000","journal-title":"Genes Dev"},{"key":"10.1016\/S0210-4806(09)72891-8_bib2","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrc1187","article-title":"Targeting HIF-1 for cancer therapy","volume":"3","author":"Semenza","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/S0210-4806(09)72891-8_bib3","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrc885","article-title":"Molecular basis of the VHL hereditary cancer syndrome","volume":"2","author":"Kaelin","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/S0210-4806(09)72891-8_bib4","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1074\/jbc.270.3.1230","article-title":"Purification and characterization of hypoxia-inducible factor 1","volume":"270","author":"Wang","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/S0210-4806(09)72891-8_bib5","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1016\/S1471-4914(02)02317-1","article-title":"HIF 1 and tumor progression: pathophysiology and therapeutics","volume":"8","author":"Semenza","year":"2002","journal-title":"Trends Mol Med"},{"key":"10.1016\/S0210-4806(09)72891-8_bib6","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2169\/internalmedicine.41.79","article-title":"Involvement of HIF 1 in human cancer","volume":"41","author":"Semenza","year":"2002","journal-title":"Intern Med"},{"key":"10.1016\/S0210-4806(09)72891-8_bib7","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1182\/blood-2004-07-2958","article-title":"Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1","volume":"105","author":"Manalo","year":"2005","journal-title":"Blood"},{"key":"10.1016\/S0210-4806(09)72891-8_bib8","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/nm0901-987","article-title":"Normalizing tumor vasculature with anti angiogenic therapy: a new paradigm for combination therapy","volume":"7","author":"Jain","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/S0210-4806(09)72891-8_bib9","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1006\/geno.1996.0311","article-title":"Assignment of the hypoxia inducible factor 1a gene to a region of conserved synteny on mouse chromosome 12 and human chromosome 14q","volume":"34","author":"Semenza","year":"1996","journal-title":"Genomics"},{"key":"10.1016\/S0210-4806(09)72891-8_bib10","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1006\/geno.1998.5416","article-title":"The human hypoxia inducible factor 1 alpha gene: HIF1A structure and evolutionary conservation","volume":"52","author":"Iyer","year":"1998","journal-title":"Genomics"},{"key":"10.1016\/S0210-4806(09)72891-8_bib11","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1101\/gad.11.1.72","article-title":"Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells","volume":"11","author":"Tian","year":"1997","journal-title":"Genes Dev"},{"key":"10.1016\/S0210-4806(09)72891-8_bib12","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1073\/pnas.94.9.4273","article-title":"A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1alpha regulates the VEGF expression and is potentially involved in lung and vascular development","volume":"94","author":"Ema","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0210-4806(09)72891-8_bib13","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0925-4773(97)00674-6","article-title":"HRF, a putative basic helix-loop-helix-PAS-domain transcription factor is closely related to hypoxia-inducible factor-1 alpha and developmentally expressed in blood vessels","volume":"63","author":"Flamme","year":"1997","journal-title":"Mech Dev"},{"key":"10.1016\/S0210-4806(09)72891-8_bib14","first-page":"205","article-title":"Molecular characterization and chromosomal localization of a third alpha-class hypoxia inducible factor subunit, HIF3alpha","volume":"7","author":"Gu","year":"1998","journal-title":"Gene Expr"},{"key":"10.1016\/S0210-4806(09)72891-8_bib15","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1096\/fj.01-0944rev","article-title":"Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factores, and O2-regulated gene expression","volume":"16","author":"Wenger","year":"2002","journal-title":"FASEB J"},{"key":"10.1016\/S0210-4806(09)72891-8_bib16","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0968-0004(96)80867-X","article-title":"Regulation of transcription factor localization: Fine-tuning of gene expression","volume":"21","author":"Vandromme","year":"1996","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/S0210-4806(09)72891-8_bib17","doi-asserted-by":"crossref","first-page":"19253","DOI":"10.1074\/jbc.272.31.19253","article-title":"Transactivation and inhibitory domains of hypoxia-inducible factor 1 alpha. Modulation of transcriptional activity by oxygen tension","volume":"272","author":"Jiang","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/S0210-4806(09)72891-8_bib18","doi-asserted-by":"crossref","first-page":"17771","DOI":"10.1074\/jbc.271.30.17771","article-title":"Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1","volume":"271","author":"Jiang","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/S0210-4806(09)72891-8_bib19","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/07391102.2000.10506656","article-title":"A model for the complex between the hypoxiainducible factor-1 (HIF-1) and its consensus DNA sequence","volume":"18","author":"Michel","year":"2000","journal-title":"J Biomol Struc Dyn"},{"key":"10.1016\/S0210-4806(09)72891-8_bib20","doi-asserted-by":"crossref","first-page":"7987","DOI":"10.1073\/pnas.95.14.7987","article-title":"Regulation of hypoxia-inducible factor 1 alpha is mediated by an O-2-dependent degradation domain via the ubiquitin- proteasome pathway","volume":"95","author":"Huang","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0210-4806(09)72891-8_bib21","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1126\/science.1059817","article-title":"HIFalpha targeted for VHLmediated destruction by proline hydroxylation: Implications for O2 sensing","volume":"292","author":"Ivan","year":"2001","journal-title":"Science"},{"key":"10.1016\/S0210-4806(09)72891-8_bib22","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1126\/science.1066373","article-title":"A conserved family of prolyl-4-hydroxylases that modify HIF","volume":"294","author":"Bruick","year":"2001","journal-title":"Science"},{"key":"10.1016\/S0210-4806(09)72891-8_bib23","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1073\/pnas.94.6.2156","article-title":"The von Hipple-Lindau tumor suppressor gene product forms a stable complex with human cul-2, a member of the Cdc53 family of proteins","volume":"94","author":"Pause","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0210-4806(09)72891-8_bib24","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1128\/MCB.18.2.732","article-title":"Regulation of hypoxia \u2013inducible mRNAs by the von Hipple-Lindau tumor suppressor protein requires binding to complexes containing elongins B\/C and Cul2","volume":"18","author":"Lonergan","year":"1998","journal-title":"Mol Cell Biol"},{"key":"10.1016\/S0210-4806(09)72891-8_bib25","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/20459","article-title":"The tumor suppressor protein VHL targets hypoxia inducible factores for oxygen \u2013dependent proteolysis","volume":"399","author":"Maxwell","year":"1999","journal-title":"Nature"},{"key":"10.1016\/S0210-4806(09)72891-8_bib26","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/35017054","article-title":"Ubiquitination of hypoxia inducible factor requires direct binding to the beta domain of the von Hipple-Lindau protein","volume":"2","author":"Ohh","year":"2000","journal-title":"Nat Cell Biol"},{"key":"10.1016\/S0210-4806(09)72891-8_bib27","doi-asserted-by":"crossref","first-page":"4298","DOI":"10.1093\/emboj\/19.16.4298","article-title":"Mechanism of regulation of the hypoxia inducible factor 1 alpha by the von Hipple Lindau tumor suppressor protein","volume":"19","author":"Tanimoto","year":"2000","journal-title":"EMBO J"},{"key":"10.1016\/S0210-4806(09)72891-8_bib28","doi-asserted-by":"crossref","first-page":"32529","DOI":"10.1074\/jbc.271.51.32529","article-title":"Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia- inducible factor 1","volume":"271","author":"Semenza","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/S0210-4806(09)72891-8_bib29","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0092-8674(01)00507-4","article-title":"C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation","volume":"107","author":"Epstein","year":"2001","journal-title":"Cell"},{"key":"10.1016\/S0210-4806(09)72891-8_bib30","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1126\/science.1073440","article-title":"Structure of an HIF-1alpha-pVHL complex: Hydroxyproline recognition in signaling","volume":"296","author":"Min","year":"2002","journal-title":"Science"},{"key":"10.1016\/S0210-4806(09)72891-8_bib31","doi-asserted-by":"crossref","first-page":"9630","DOI":"10.1073\/pnas.181341498","article-title":"HIF-1alpha binding to VHL is regulated by stimulus-sensitive proline hydroxylation","volume":"98","author":"Yu","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0210-4806(09)72891-8_bib32","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1126\/science.1059796","article-title":"Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation","volume":"292","author":"Jaakkola","year":"2001","journal-title":"Science"},{"key":"10.1016\/S0210-4806(09)72891-8_bib33","doi-asserted-by":"crossref","first-page":"5197","DOI":"10.1093\/emboj\/20.18.5197","article-title":"Independent function of two destruction domains in hypoxiainducible factor-alpha chains activated by prolyl hydroxylation","volume":"20","author":"Masson","year":"2001","journal-title":"EMBO J"},{"key":"10.1016\/S0210-4806(09)72891-8_bib34","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0092-8674(02)01085-1","article-title":"Regulation and destabilization of HIF-1alpha by ARD1-mediated acetylation","volume":"111","author":"Jeong","year":"2002","journal-title":"Cell"},{"key":"10.1016\/S0210-4806(09)72891-8_bib35","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1126\/science.1068592","article-title":"Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch","volume":"295","author":"Lando","year":"2002","journal-title":"Science"},{"key":"10.1016\/S0210-4806(09)72891-8_bib36","doi-asserted-by":"crossref","first-page":"7658","DOI":"10.1158\/1078-0432.CCR-05-0460","article-title":"The androgen receptor is significantly associated with vascular endothelial growth factor and hypoxia sensing via HIF1a, HIF2a and the prolyl hydroxylases in human prostate cancer","volume":"11","author":"Boddy","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/S0210-4806(09)72891-8_bib37","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/sj.bjc.6601657","article-title":"Gene array of VHL mutation and hipoxia shows novel hipoxia induced genes and that cyclin D1 is a VHL target gene","volume":"90","author":"Wykoff","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/S0210-4806(09)72891-8_bib38","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1158\/1541-7786.MCR-06-0235","article-title":"Inhibiting hypoxia inducible factor 1 for cancer therapy","volume":"4","author":"Melillo","year":"2006","journal-title":"Mol Cancer Res"},{"key":"10.1016\/S0210-4806(09)72891-8_bib39","doi-asserted-by":"crossref","first-page":"40112","DOI":"10.1074\/jbc.M206922200","article-title":"Role of prolyl hydroxylation in oncogenically stabilized hypoxia-inducible factor-1alpha","volume":"277","author":"Chan","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/S0210-4806(09)72891-8_bib40","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1126\/science.7521539","article-title":"Control of angiogenesis in fibroblasts by P53 regulation of thrombospondin-1","volume":"265","author":"Dameron","year":"1994","journal-title":"Science"},{"key":"10.1016\/S0210-4806(09)72891-8_bib41","first-page":"2288","article-title":"Adenovirus-mediated wild-type p53 gene transfer down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human colon cancer","volume":"58","author":"Bouvet","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/S0210-4806(09)72891-8_bib42","first-page":"7349","article-title":"Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxiainducible factor (HIF)-1 alpha, HIF-2 alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3 \u2018-kinase\/Akt signaling pathway","volume":"61","author":"Blancher","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/S0210-4806(09)72891-8_bib43","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1128\/MCB.21.12.3995-4004.2001","article-title":"HER2 (neu) signaling increases the rate of hypoxiainducible factor 1alpha (HIF-1alpha) synthesis: Novel mechanism for HIF-1-mediated vascular endothelial growth factor expression","volume":"21","author":"Laughner","year":"2001","journal-title":"Mol Cell Biol"},{"key":"10.1016\/S0210-4806(09)72891-8_bib44","doi-asserted-by":"crossref","first-page":"15162","DOI":"10.1074\/jbc.M111162200","article-title":"Phosphatidylinositol 3-kinase\/Akt signaling is neither required for hypoxic stabilization of HIF-1 alpha nor sufficient for HIF-1-dependent target gene transcription","volume":"277","author":"Arsham","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/S0210-4806(09)72891-8_bib45","doi-asserted-by":"crossref","first-page":"31277","DOI":"10.1074\/jbc.M300763200","article-title":"Regulation of hypoxia-inducible factor-1alpha protein level during hypoxic conditions by the phosphatidylinositol 3-kinase\/Akt\/glycogen synthase kinase 3beta pathway in HepG2 cells","volume":"278","author":"Mottet","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/S0210-4806(09)72891-8_bib46","first-page":"1541","article-title":"Modulation of hypoxiainducible factor 1 alpha expression by the epidermal growth factor\/phosphatidylinositol 3- inase\/PTEN\/AKT\/FRAP pathway in human prostate cancer cells: Implications for tumor angiogenesis and therapeutics","volume":"60","author":"Zhong","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/S0210-4806(09)72891-8_bib47","first-page":"2416","article-title":"Androgens stimulate hypoxia-inducible factor 1 activation via autocrine loop of tyrosine kinase receptor\/phosphatidylinositol 3\u2019-kinase\/protein kinase B in prostate cancer cells","volume":"9","author":"Mabjeesh","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/S0210-4806(09)72891-8_bib48","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0165-4608(01)00396-X","article-title":"Amplification of HIF 1a gene in prostate cancer","volume":"128","author":"Outi","year":"2001","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/S0210-4806(09)72891-8_bib49","doi-asserted-by":"crossref","first-page":"31963","DOI":"10.1074\/jbc.M200082200","article-title":"Vanadate-induced expression of hypoxia-inducible factor 1 alpha and vascular endothelial growth factor through phosphatidylinositol 3-kinase\/Akt pathway and reactive oxygen species","volume":"277","author":"Gao","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/S0210-4806(09)72891-8_bib50","doi-asserted-by":"crossref","first-page":"45041","DOI":"10.1074\/jbc.M202775200","article-title":"p38 aignaling-mediated hypoxia- inducible factor 1alpha and vascular endothelial growth factor induction by Cr(VI) in DU145 human prostate carcinoma cells","volume":"277","author":"Gao","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/S0210-4806(09)72891-8_bib51","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0014-5793(01)02833-2","article-title":"A non-hypoxic, ROS-sensitive pathway mediates TNF-alpha-dependent regulation of HIF-1alpha","volume":"505","author":"Haddad","year":"2001","journal-title":"FEBS Lett"},{"key":"10.1016\/S0210-4806(09)72891-8_bib52","doi-asserted-by":"crossref","first-page":"25130","DOI":"10.1074\/jbc.M001914200","article-title":"Reactive oxygen species generated at mitochondrial complex III stabilize hypoxiainducible factor-1 alpha during hypoxia - A mechanism of O-2 sensing","volume":"275","author":"Chandel","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/S0210-4806(09)72891-8_bib53","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/978-1-4684-3291-6_98","article-title":"Proposal for using a standardized terminology on oxygen transport to tissue","volume":"191","author":"Zander","year":"1985","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/S0210-4806(09)72891-8_bib54","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1096\/fj.01-0125com","article-title":"HIF-1 is expressed in normoxic tissue and displays an organ-specific regulation under systemic hypoxia","volume":"15","author":"Stroka","year":"2001","journal-title":"FASEB J"},{"key":"10.1016\/S0210-4806(09)72891-8_bib55","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.3748\/wjg.v10.i8.1082","article-title":"Hypoxia-inducible factor-1 in tumor angiogenesis","volume":"10","author":"Yong-HS","year":"2004","journal-title":"World J Gastroenterol"},{"key":"10.1016\/S0210-4806(09)72891-8_bib56","first-page":"6449","article-title":"Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review","volume":"49","author":"Vaupel","year":"1989","journal-title":"Cancer Res"},{"key":"10.1016\/S0210-4806(09)72891-8_bib57","first-page":"5522","article-title":"Fluctuations in red cell flux in tumor microvessels can lead to transient hypoxia and reoxygenation in tumor parenchyma","volume":"56","author":"Kimura","year":"1996","journal-title":"Cancer Res"},{"key":"10.1016\/S0210-4806(09)72891-8_bib58","first-page":"1408","article-title":"The unique physiology of solid tumors: opportunities (and problems) for cancer therapy","volume":"58","author":"Brown","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/S0210-4806(09)72891-8_bib59","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1053-4296(98)80040-4","article-title":"Concepts of oxygen transport at the microcirculatory level","volume":"8","author":"Dewhirst","year":"1998","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/S0210-4806(09)72891-8_bib60","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1677\/erc.1.00728","article-title":"Hypoxia-inducible factor in human breast and prostate cancer","volume":"13","author":"Kimbro","year":"2006","journal-title":"Endocrine Related Cancer"},{"key":"10.1016\/S0210-4806(09)72891-8_bib61","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.cmet.2005.05.006","article-title":"ROS: really involved in oxygen sensing","volume":"1","author":"Kaelin","year":"2005","journal-title":"Cell Metabolism"},{"key":"10.1016\/S0210-4806(09)72891-8_bib62","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1080\/10715760400029710","article-title":"Nitric Oxide enhances catechol estrogen induced oxidative stress in LNCaP cells","volume":"39","author":"Muzandu","year":"2005","journal-title":"Free Radical Research"},{"key":"10.1016\/S0210-4806(09)72891-8_bib63","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1146\/annurev.cellbio.15.1.551","article-title":"Regulation of mammalian O2 homeostasis by hypoxia inducible factor 1","volume":"15","author":"Semenza","year":"1999","journal-title":"Annu Ver Cell Dev Biol"},{"key":"10.1016\/S0210-4806(09)72891-8_bib64","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1182\/blood.V89.2.503","article-title":"Induction of hypoxia inducible factor 1, erythropoietin, vascular endothelial growth factor and glucose transporter 1 by hypoxia: evidence against a regulatory role for Src kinase","volume":"89","author":"Gleadle","year":"1997","journal-title":"Blood"},{"key":"10.1016\/S0210-4806(09)72891-8_bib65","first-page":"928","article-title":"Glucose transporter glut 1 expression correlates with tumor hypoxia and predicts metastasis free survival in advanced carcinoma of the cervix","volume":"7","author":"Airley","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1016\/S0210-4806(09)72891-8_bib66","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/nrc2344","article-title":"Hypoxia, DNA repair and genetic instability","volume":"8","author":"Bristow","year":"2008","journal-title":"Hill in Nature Reviews"},{"key":"10.1016\/S0210-4806(09)72891-8_bib67","first-page":"3814","article-title":"GADD45 and GADD153 messenger RNA levels are increased during hypoxia and after exposure of cells to agents which elevate the levels of the glucose regulated proteins","volume":"52","author":"Prince","year":"1992","journal-title":"Cancer Res"},{"key":"10.1016\/S0210-4806(09)72891-8_bib68","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1146\/annurev.med.54.101601.152418","article-title":"Angiogenesis in ischemic and neoplastic disorders","volume":"54","author":"Semenza","year":"2003","journal-title":"Annu Rev Med"},{"key":"10.1016\/S0210-4806(09)72891-8_bib69","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/S0959-8049(00)00159-3","article-title":"Hypoxia modulated gene expression: angiogenesis, metastasis and therapeutic exploitation","volume":"36","author":"Dachs","year":"2000","journal-title":"Eur J Cancer"},{"key":"10.1016\/S0210-4806(09)72891-8_bib70","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1128\/MCB.16.9.4604","article-title":"Activation of vascular endothelial growth factor gene transcription by hypoxia inducible factor 1","volume":"16","author":"Forsythe","year":"1996","journal-title":"Mol Cell Biol"},{"key":"10.1016\/S0210-4806(09)72891-8_bib71","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0002-9440(10)64554-3","article-title":"The expression and distribution of the hypoxiainducible factors HIF-1 alpha and HIF-2 alpha in normal human tissues, cancers, and tumor-associated macrophages","volume":"157","author":"Talks","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/S0210-4806(09)72891-8_bib72","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/jnci\/93.4.309","article-title":"Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis","volume":"93","author":"Bos","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/S0210-4806(09)72891-8_bib73","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1054\/bjoc.2001.2018","article-title":"Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic\/molecular profile of tumours and survival","volume":"85","author":"Giatromanolaki","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1016\/S0210-4806(09)72891-8_bib74","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3748\/wjg.v9.i2.312","article-title":"Angiogenesis effect on rat liver after administration of expression vector encoding vascular endothelial growth factor D","volume":"9","author":"Shi","year":"2003","journal-title":"World J Gastroenterol"},{"key":"10.1016\/S0210-4806(09)72891-8_bib75","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1111\/j.1349-7006.1994.tb02904.x","article-title":"Association of vascular endothelial growth-factor expression with tumor angiogenesis and with early relapse in primary breastcancer","volume":"85","author":"Toi","year":"1994","journal-title":"Jpn Cancer Res"},{"key":"10.1016\/S0210-4806(09)72891-8_bib76","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/(SICI)1097-0142(19960301)77:5<858::AID-CNCR8>3.0.CO;2-A","article-title":"Prognostic value of vascular endothelial growth factor expression in gastric carcinoma","volume":"77","author":"Maeda","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/S0210-4806(09)72891-8_bib77","first-page":"2736","article-title":"Angiogenesis and prostate cancer: Identification of a molecular progression switch","volume":"61","author":"Huss","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/S0210-4806(09)72891-8_bib78","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1023\/A:1006040928755","article-title":"New targets, drugs and approaches for the treatment of cancer: an overview","volume":"17","author":"Kerbel","year":"1998","journal-title":"Cancer Metastasis Rev"},{"issue":"Suppl 5","key":"10.1016\/S0210-4806(09)72891-8_bib79","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1634\/theoncologist.9-90005-10","article-title":"The role of hypoxia induced factores in tumor progression","volume":"9","author":"Vaupel","year":"2004","journal-title":"Oncologist"},{"key":"10.1016\/S0210-4806(09)72891-8_bib80","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0093-7754(01)90210-6","article-title":"Oxygen status of malignant tumors: pathogenesis of hypoxia and significance for tumor therapy","volume":"28","author":"Vaupel","year":"2001","journal-title":"Seminars in Oncology"},{"key":"10.1016\/S0210-4806(09)72891-8_bib81","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1002\/cncr.20244","article-title":"Prognostic significance of erythropoietin expression in human endometrial carcinoma","volume":"100","author":"Acs","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/S0210-4806(09)72891-8_bib82","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1136\/jcp.2004.019885","article-title":"Differential prognostic impact of hypoxia induced and diffuse HIF-1alpha expression in invasive breast cancer","volume":"58","author":"Vleugel","year":"2005","journal-title":"J Clin Pathol"},{"key":"10.1016\/S0210-4806(09)72891-8_bib83","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2217\/14796694.3.3.329","article-title":"Tumor hypoxia, DNA repair and prostate cancer progression: new targets and new therapies","volume":"3","author":"Chan","year":"2007","journal-title":"Future Oncol"},{"key":"10.1016\/S0210-4806(09)72891-8_bib84","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1158\/1078-0432.CCR-06-2971","article-title":"Hypoxia and metastasis","volume":"13","author":"Chaudary","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/S0210-4806(09)72891-8_bib85","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10555-007-9055-1","article-title":"Hypoxia in cancer: significance and impact in clinical outcome","volume":"26","author":"Vaupel","year":"2007","journal-title":"Cancer Metastasis Ver"},{"key":"10.1016\/S0210-4806(09)72891-8_bib86","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1096\/fasebj.11.5.9141507","article-title":"Aerobic glycolysis by proliferating cells: a protective strategy against reactive oxygen species","volume":"11","author":"Brand","year":"1997","journal-title":"FASEB J"},{"key":"10.1016\/S0210-4806(09)72891-8_bib87","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/nrc1478","article-title":"Why do cancers have high aerobic glycolysis?","volume":"4","author":"Gatenby","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/S0210-4806(09)72891-8_bib88","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.canlet.2004.12.040","article-title":"Glucose requirement for hypoxic accumulation of hypoxia inducible factor 1alpha","volume":"230","author":"Vordermark","year":"2005","journal-title":"Cancer Lett"},{"key":"10.1016\/S0210-4806(09)72891-8_bib89","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/sj.bjc.6602828","article-title":"Angiogenesis and hypoxia in lymph node metastasis is predicted by the angiogenesis and hypoxia in the primary tumour in patients with breast cancer","volume":"93","author":"Van den Eynden","year":"2005","journal-title":"BR J Cancer"},{"key":"10.1016\/S0210-4806(09)72891-8_bib90","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1152\/jappl.2000.88.4.1474","article-title":"HIF-1: mediator of physiological and pathophysiological responses to hypoxia","volume":"88","author":"Semenza","year":"2000","journal-title":"J Appl Physiol"},{"key":"10.1016\/S0210-4806(09)72891-8_bib91","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1093\/emboj\/17.11.3005","article-title":"HIF-1 alpha is required for solid tumor formation and embryonic vascularization","volume":"17","author":"Ryan","year":"1998","journal-title":"Embol J"},{"key":"10.1016\/S0210-4806(09)72891-8_bib92","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1007\/s00109-002-0355-1","article-title":"A role of hypoxia and hypoxia inducible transcription factores in tumor physiology","volume":"80","author":"Acker","year":"2002","journal-title":"J Mol Med"},{"key":"10.1016\/S0210-4806(09)72891-8_bib93","first-page":"562","article-title":"A role of hypoxia in tumor angiogenesis \u2013molecular and cellular angiogenic crosstalk","volume":"80","author":"Acker","year":"2003","journal-title":"Cell Tissue Res"},{"key":"10.1016\/S0210-4806(09)72891-8_bib94","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0074-7696(04)42004-X","article-title":"The hypoxia inducible factor and tumor progression along the angiogenic pathway","volume":"242","author":"Brahimi-Horn","year":"2005","journal-title":"Int Rev Cytol"},{"key":"10.1016\/S0210-4806(09)72891-8_bib95","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nm0603-677","article-title":"Regulation of angiogenesis by hypoxia: role of the HIF system","volume":"9","author":"Pugh","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/S0210-4806(09)72891-8_bib96","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nm0603-669","article-title":"The biology of VEGF and its receptores","volume":"9","author":"Ferrara","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/S0210-4806(09)72891-8_bib97","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1093\/jnci\/87.21.1603","article-title":"Angiogenesis in bladder cancer relationship between microvessel density and tumor prognosis","volume":"87","author":"Bochner","year":"1995","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/S0210-4806(09)72891-8_bib98","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0022-5347(01)67230-6","article-title":"Tumor angiogenesis correlateswith lymph-node metastases in invasive bladder-cancer","volume":"154","author":"Jaeger","year":"1995","journal-title":"J Urol"},{"key":"10.1016\/S0210-4806(09)72891-8_bib99","first-page":"5830","article-title":"Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases","volume":"59","author":"Zhong","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/S0210-4806(09)72891-8_bib100","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1002\/cncr.11246","article-title":"Levels of hypoxiainducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma","volume":"97","author":"Bos","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/S0210-4806(09)72891-8_bib101","first-page":"1661","article-title":"Expression of hypoxia-inducible factor 1alpha in epithelial ovarian tumors: its impact on prognosis and on response to chemotherapy","volume":"7","author":"Birner","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1016\/S0210-4806(09)72891-8_bib102","first-page":"2911","article-title":"Expression of hypoxia-inducible factor-1alpha: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer","volume":"61","author":"Aebersold","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/S0210-4806(09)72891-8_bib103","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/jnci\/93.4.266","article-title":"Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects","volume":"93","author":"Hockel","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/S0210-4806(09)72891-8_bib104","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1093\/emboj\/cdg173","article-title":"The VHL protein recruits a novel KRAB-A domain protein to repress HIF-1alpha transcriptional activity","volume":"22","author":"Li","year":"2003","journal-title":"EMBO J"},{"key":"10.1016\/S0210-4806(09)72891-8_bib105","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S1535-6108(02)00043-0","article-title":"Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein","volume":"1","author":"Kondo","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/S0210-4806(09)72891-8_bib106","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.urology.2003.09.059","article-title":"Radical prostatectomy lowers plasma vascular endothelial growth factor levels in patients with prostate cancer","volume":"63","author":"George","year":"2004","journal-title":"Urology"},{"key":"10.1016\/S0210-4806(09)72891-8_bib107","first-page":"1138","article-title":"Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1","volume":"63","author":"Krishnamachary","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/S0210-4806(09)72891-8_bib108","first-page":"5280","article-title":"Increased expression of hypoxia inducible factor 1 alpha in rat and human prostate cancer","volume":"58","author":"Zhong","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/S0210-4806(09)72891-8_bib109","doi-asserted-by":"crossref","first-page":"27975","DOI":"10.1074\/jbc.M204152200","article-title":"Insulin stimulates hypoxia-inducible factor 1 through a phosphatidylinositol 3-kinase\/target of rapamycindependent signaling pathway","volume":"277","author":"Treins","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/S0210-4806(09)72891-8_bib110","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0014-5793(02)02247-0","article-title":"Normoxic induction of the hypoxia-inducible factor 1alpha by insulin and interleukin-1beta involves the phosphatidylinositol 3-kinase pathway","volume":"512","author":"Stiehl","year":"2002","journal-title":"FEBS Lett"},{"key":"10.1016\/S0210-4806(09)72891-8_bib111","first-page":"1408","article-title":"The unique physiology of solid tumors: opportunities and problems for cancer therapy","volume":"58","author":"Brown","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/S0210-4806(09)72891-8_bib112","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1096\/fj.02-0358fje","article-title":"Regulation of the multidrug resistance transporter P-glycoprotein in multicellular tumor spheroids by hypoxia-inducible factor (HIF-1) and reactive oxygen species","volume":"17","author":"Wartenberg","year":"2003","journal-title":"FASEB J"},{"key":"10.1016\/S0210-4806(09)72891-8_bib113","first-page":"3387","article-title":"Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene","volume":"62","author":"Comerford","year":"2002","journal-title":"Cancer Res"}],"container-title":["Actas Urol\u00f3gicas Espa\u00f1olas"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210480609728918?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210480609728918?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T21:32:40Z","timestamp":1646515960000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0210480609728918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":113,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S0210480609728918"],"URL":"https:\/\/doi.org\/10.1016\/s0210-4806(09)72891-8","relation":{},"ISSN":["0210-4806"],"issn-type":[{"value":"0210-4806","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}